Steven Cohen's HNGE Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 269,106 shares of Hinge Health, Inc. (HNGE) worth $22.34 M, representing 0.02% of the portfolio. First purchased in 2025-Q2, this short-term holding has been held for 5 quarters.
Based on 13F filings, Steven Cohen has maintained this position in HNGE for several quarters, showing initial confidence in the investment. Largest addition occurred in Q1 2026, adding 68,785 shares. Largest reduction occurred in Q4 2025, reducing 166,910 shares.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's Hinge Health (HNGE) Holding Value Over Time
Track share changes against reported price movement
Quarterly Hinge Health (HNGE) Trades by Steven Cohen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | -78,102 | Reduce 22.49% | 269,106 | $83.00 |
| Q1 2026 | +68,785 | Add 24.71% | 347,208 | $38.56 |
| Q4 2025 | -166,910 | Reduce 37.48% | 278,423 | $46.45 |
| Q3 2025 | -102,606 | Reduce 18.73% | 445,333 | $49.08 |
| Q2 2025 | +547,939 | New Buy | 547,939 | $51.75 |
Steven Cohen's Hinge Health Investment FAQs
Steven Cohen first purchased Hinge Health, Inc. (HNGE) in Q2 2025, acquiring 547,939 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held Hinge Health, Inc. (HNGE) for 5 quarters since Q2 2025.
Steven Cohen's largest addition to Hinge Health, Inc. (HNGE) was in Q2 2025, adding 547,939 shares worth $28.36 M.
According to the latest 13F filing for Q2 2026, Steven Cohen's firm, Point72 Asset Management, L.P., owns 269,106 shares of Hinge Health, Inc. (HNGE), valued at approximately $22.34 M.
As of the Q2 2026 filing, Hinge Health, Inc. (HNGE) represents approximately 0.02% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.
Steven Cohen's peak holding in Hinge Health, Inc. (HNGE) was 547,939 shares, as reported at the end of Q2 2025.